Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study. (Q54337668)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study. |
scientific article |
Statements
Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study. (English)
Mareile Joka
Stefan Boeck
Christoph J Zech
Thomas Seufferlein
Goetz von Wichert
Thomas Licht
Annekatrin Krause
Karl-Walter Jauch
Volker Heinemann
Christiane J Bruns
1 October 2014
25
9
1095-1101